GLUTATHIONE Peptide – User Manual & Dosage Protocol Guide

1

Product Overview

Glutathione Peptide is a tripeptide composed of glutamine, cysteine, and glycine, and is widely studied for its antioxidant and detoxification properties. It plays a critical role in:

  • Neutralizing free radicals and reactive oxygen species
  • Supporting liver detoxification pathways
  • Enhancing skin health and complexion
  • Supporting immune system function

Disclaimer: Glutathione peptide is for research and experimental use only. It is not FDA-approved for medical or cosmetic purposes. Consult a qualified healthcare professional before use.

2

Forms Available

Product Form

Lyophilized Powder

  • Description: Freeze-dried glutathione peptide for reconstitution

Injection Solution

  • Description: Subcutaneous or intravenous solution after reconstitution

Oral Capsules

  • Description: Alternative delivery method; bioavailability may be lower compared to injections
3

Mechanism of Action

Glutathione peptide works by:

  • Acting as a powerful intracellular antioxidant
  • Reducing oxidative stress and protecting cells from damage
  • Supporting detoxification in liver and kidneys
  • Potentially improving skin tone and overall cellular health

Effects are primarily observed in research studies and limited clinical investigations.

4

Dosage Protocol (Investigational)

Administration

Subcutaneous (SC) Injection

  • Typical Dose: 600–1200 mg
  • Frequency: 1–3× per week
  • Notes: Preferred for research or cosmetic purposes

Intravenous (IV) Injection

  • Typical Dose: 600–1200 mg
  • Frequency: 1–2× per week
  • Notes: Often used in clinical or research settings for rapid effect

Oral Capsules

  • Typical Dose: 250–500 mg
  • Frequency: Daily
  • Notes: Bioavailability may be limited due to digestion
Cycle Protocol (Investigational)

Initial Phase

  • Duration: 2–4 weeks
  • Dose: Lower end of dosing range
  • Notes: Monitor tolerance and effect

Therapeutic Phase

  • Duration: 4–8 weeks
  • Dose: Full dose range
  • Notes: Maximum antioxidant and detox effects

Rest Period

  • Duration: 1–2 months
  • Dose: None
  • Notes: Allow the body to reset before the next cycle

Experimental protocols may repeat 2–4 cycles per year, depending on research goals.

5

Reconstitution Instructions (Lyophilized Powder)

Supplies Needed:

  • Sterile bacteriostatic water
  • Sterile syringe
  • Alcohol swabs

Steps:

  1. Clean vial with alcohol swab.
  2. Add desired volume of bacteriostatic water (e.g., 600 mg peptide + 2 mL water → 300 mg/mL solution).
  3. Swirl gently to dissolve; do not shake.
  4. Store refrigerated (2–8°C).
  5. Use within 2–4 weeks; discard if cloudy or discolored.
6

Administration Guidelines

Subcutaneous Injection (SC)
  1. Select clean injection site (abdomen, thigh, or upper arm).
  2. Clean the site with alcohol swab.
  3. Insert needle at 45° angle.
  4. Inject slowly and steadily.
  5. Apply gentle pressure; rotate injection sites weekly.
Intravenous Injection (IV)
  • Administered slowly via trained personnel.
  • Ensure sterile technique and proper dilution.
  • Monitor patient/research subject for any adverse reactions.
Oral Capsules
  • Take on an empty stomach for better absorption.
  • Daily consistent dosing is recommended.
7

Storage Guidelines

Storage Information

Lyophilized Powder

  • Storage: Cool, dry place
  • Shelf Life: Up to 12 months

Reconstituted Solution

  • Storage: Refrigerate at 2–8°C
  • Shelf Life: 2–4 weeks

Oral Capsules

  • Storage: Room temperature, dry place
  • Shelf Life: 12 months
8

Safety & Precautions

  • Not recommended for pregnant or breastfeeding women
  • Avoid use if allergic to peptides
  • Mild side effects: irritation at injection site, mild nausea
  • Discontinue if severe adverse reactions occur
  • Keep out of reach of children

Effects in humans are primarily investigational.

9

Quick Reference Cycle Chart (Investigational)

Weekly Cycle Schedule

Week 1–2

  • Dose: 600 mg SC/IV, 1× per week
  • Notes: Initial tolerance phase

Week 3–4

  • Dose: 800 mg SC/IV, 1–2× per week
  • Notes: Gradual increase

Week 5–8

  • Dose: 1000–1200 mg SC/IV, 2–3× per week
  • Notes: Full therapeutic cycle

Week 9+

  • Dose: Rest
  • Notes: 1–2 month break before the next cycle
10

Visual Guide

  • Diagrams of SC and IV injection sites (abdomen, thigh, arm, forearm)
  • Step-by-step reconstitution guide
  • Safety icons for handling, storage, and injections